Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,732
Closed -$590K 157
2023
Q2
$590K Sell
1,732
-2,051
-54% -$637K 0.03% 604
2023
Q1
$1.12M Sell
3,783
-85
-2% -$25.1K 0.04% 450
2022
Q4
$1.16M Sell
3,868
-2,445
-39% -$713K 0.04% 417
2022
Q3
$1.65M Buy
6,313
+4,687
+288% +$1.32M 0.06% 327
2022
Q2
$458K Buy
+1,626
New +$452K 0.01% 877
2022
Q1
Sell
-1,522
Closed -$410K 1252
2021
Q4
$410K Buy
+1,522
New +$417K 0.02% 718
2021
Q3
Sell
-5,800
Closed -$1.48M 1247
2021
Q2
$1.48M Buy
+5,800
New +$1.5M 0.03% 416
2021
Q1
Sell
-4,600
Closed -$1.15M 818
2020
Q4
$1.15M Sell
4,600
-2,855
-38% -$658K 0.04% 310
2020
Q3
$1.59M Buy
+7,455
New +$1.61M 0.21% 85

Other funds holding CACI

Ergoteles's CACI Position: Q3 2023 in Review

Ergoteles sold out of CACI (CACI) in Q3 2023, closing a stake of 1,732 shares — an estimated $590K sold.

Ergoteles first reported a position in CACI in Q3 2020 and held it in 9 quarters. The position peaked at $1.65M in Q3 2022. 443 funds tracked by Wall St. Rank hold CACI as of Q3 2023.

  • Ergoteles reported no remaining CACI position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 1,732 CACI shares in Q3 2023, an estimated $590K.
  • Ergoteles first reported a position in CACI in Q3 2020 and held it in 9 quarters.
  • Ergoteles's CACI position peaked at $1.65M in Q3 2022.
  • 443 funds tracked by Wall St. Rank held CACI as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.